Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III in Human Plasms and Human Urine Using LC-MS/MS

In this study, we developed and validated an LC-MS/MS method for the simultaneous determination of CP-I and CP-III in human plasma with the lowest LLOQ limit.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Comments

This field is for validation purposes and should be left unchanged.

Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III in Human Plasms and Human Urine Using LC-MS/MS

Resources to Consider

Quantitation of Four Chiral Drug Compounds Simultaneously Using…

Development and Validation of an LC-MS.MS Method for the Simultaneous...

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous...

Simultaneous Quantification Of Total Antibody And...

Validation of a Low-Volume Plasma LC-MS/MS Method Using a...

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...

High Throughput Sample Analysis Using Gyrolab

Preclinical Drug Screening Using Gyrolab

Neurofilament Light Chain: Method Validation of Quantitation Using...

Surrogate Analyte Approaches in Bioanalysis using LC-MS-MS

Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption

Intraperitoneal Dose Administration: Successful Testing Using IP...